Scientists react to MHRA approving semaglutide for heart problems. Prof John Wilding, Professor of Medicine, Department of Cardiovascular and … read more
A study published in JAMA Ophthalmology looks at optic neuropathy as a possible side effect of semaglutide. Prof Graham McGeown, … read more
A presentation at the International Congress on Obesity looks at ultra-processed foods pushing aside other food groups. Prof Gunter … read more
Scientists react to NICE publishing draft guidance on tirzepatide for obesity. Dr Simon Cork, Senior Lecturer in Physiology, Anglia … read more
A conference abstract presented at the European Congress on Obesity looks at BMI thresholds for obesity in over 40s. … read more
A study published in Nature Medicine and an accompanying conference abstract and poster looks at long term weight loss effects of semaglutide … read more
A study published in Annals of Internal Medicine looks at the effect of time-restricted eating on body weight. Dr Jacopo Scotucci, … read more
A study published in the Lancet looks at semaglutide and obesity-related heart failure. Prof Kazem Rahimi, Professor of Cardiovascular Medicine … read more
A study published in the New England Journal of Medicine looks at semaglutide and heart failure in patients with … read more
A study published in eBioMedicine looks at sweeteners and appetite in obese adults. Prof Kevin McConway, Emeritus Professor of Applied Statistics, … read more
Scientists react to obesity conference abstracts about sweeteners and weight loss control. Prof Kevin McConway, Emeritus Professor of Applied … read more
A study published in BMJ Nutrition, Prevention & Health looks at apple cider vinegar for weight management in adolescents and young children … read more
A study published in the Lancet Public Health looks at calorie labelling, obesity and deaths from cardiovascular disease (CVD). Prof Sir … read more
The press release from Novo Nordisk states that semaglutide 2.4 mg reduces the risk of major adverse cardiovascular events by … read more
The press release from Eli Lilly states that their drug tirzepatide demonstrated significant and superior weight loss compared to placebo … read more
A new suite of injectable weight loss drugs – GLP-1 receptor agonists – has arrived on the scene in the … read more
A study published in Nature Metabolism looks at brain responses to nutrients after weight loss in humans with obesity. … read more
The 2-year drugs pilot was announced by the Prime Minister Rishi Sunak today. Prof Giles Yeo, Professor of Molecular … read more
A conference abstract (not a published paper) presented at the European Congress on Obesity (ECO) looks at cardiovascular risk in patients … read more
